BioCentury | Jan 2, 2012
Company News

Akorn, Lundbeck deal

...Inc. subsidiary acquired three off-patent injectables from H. Lundbeck's U.S. subsidiary - Nembutal pentobarbital, Diuril chlorothiazide...
...$30-$35 million in 2012 revenue. Nembutal, a barbiturate, is indicated to treat insomnia and convulsions. Diuril...
BioCentury | Mar 5, 2007
Company News

Salix, Merck sales and marketing update

...SLXP acquired gastrointestinal drugs Pepcid famotidine oral suspension and Diuril chlorothiazide oral suspension from MRK for...
...U.S. sales in 2006, according to SXLP. MRK did not break out 2006 sales for Diuril...
...a histamine H2 receptor antagonist, is used to treat ulcers and gastroesophageal reflux disease (GERD). Diuril...
BioCentury | Mar 1, 2007
Financial News

Salix gets $100 million facility, gastrointestinal products

...use the facility in part to help finance the acquisition of Pepcid Oral Suspension and Diuril...
...sales of $20 million, according to SLXP. MRK did not break out 2006 sales for Diuril...
Items per page:
1 - 3 of 3